40
Participants
Start Date
June 1, 2025
Primary Completion Date
December 1, 2025
Study Completion Date
January 1, 2026
Remimazolam
Remimazolam, sufentanil and rocuronium were used during induction, and remimazolam and refentanil were used during maintenance
propofol
Propofol, sufentanil and rocuronium were used during induction, and propofol and remifentanil were used during maintenance
Second Hospital of Shanxi Medical University
OTHER